BEAM Stock Analysis: Buy, Sell, or Hold?
BEAM - Beam Therapeutics Inc. Common Stock
$31.29
-1.39 (-4.25%)
▼
5d:
-11.41%
30d:
+6.1%
90d:
+14.07%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Smart Money Accumulation
None View Scanner →
Strength: 5.9/10
Get Alerted When BEAM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BEAM is down 11.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BEAM is down 11.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BEAM is currently trading at $31.29, which is considered fair relative to its 30-day fair value range of $30.17 to $35.28.
Technical Outlook: Technically, BEAM is in a uptrend. The price is currently testing key support at $31.34. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $51.36 (+57.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BEAM is in a uptrend. The price is currently testing key support at $31.34. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $51.36 (+57.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$30.17 -
$35.28
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
Holding BEAM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 57.2% below Wall St target ($51.36)
- WARNING: Recommendation downgraded due to -11.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$30.17 -
$35.28
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$31.34
Resistance Level
$38.26
Current Trend
Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.91
Wall Street Target
$51.36
(+57.2%)
Revenue Growth (YoY)
324.9%
Profit Margin
-40.2%
Share & Embed Analysis
Last updated: July 13, 2026 11:18 AM ET
Data refreshes hourly during market hours. Next update: 12:18 PM
Data refreshes hourly during market hours. Next update: 12:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BEAM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Amy Simon
SELL
6700 shares
2026-04-01
Christine Bellon
SELL
5956 shares
2026-04-01
Giuseppe Ciaramella
SELL
11810 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 57 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
Advanced BEAM Option Strategies
Professional options setups generated by AI based on today's BEAM price and gamma walls.
